A Study of Two Approved Drugs in Patients With Osteoarthritis (0966-219)

NCT00092352 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

395

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis

Interventions

DRUG: MK0966, rofecoxib
DRUG: Comparator: celecoxib, placebo

Sponsor

Merck Sharp & Dohme LLC